NZ229174A - Hydroxamate derivatives of selected nonsteroidal anti-inflammatory drugs carrying an acyl linkage and their pharmaceutical compositions - Google Patents
Hydroxamate derivatives of selected nonsteroidal anti-inflammatory drugs carrying an acyl linkage and their pharmaceutical compositionsInfo
- Publication number
- NZ229174A NZ229174A NZ229174A NZ22917489A NZ229174A NZ 229174 A NZ229174 A NZ 229174A NZ 229174 A NZ229174 A NZ 229174A NZ 22917489 A NZ22917489 A NZ 22917489A NZ 229174 A NZ229174 A NZ 229174A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pharmaceutical compositions
- inflammatory drugs
- nonsteroidal anti
- hydroxamate derivatives
- acyl linkage
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/04—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers
- C07C257/06—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers having carbon atoms of imino-carboxyl groups bound to hydrogen atoms, to acyclic carbon atoms, or to carbon atoms of rings other than six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
- C07C317/40—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/196,584 US4943587A (en) | 1988-05-19 | 1988-05-19 | Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues and their use for cyclooxygenase and 5-lipoxygenase inhibition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ229174A true NZ229174A (en) | 1991-08-27 |
Family
ID=22725977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ229174A NZ229174A (en) | 1988-05-19 | 1989-05-17 | Hydroxamate derivatives of selected nonsteroidal anti-inflammatory drugs carrying an acyl linkage and their pharmaceutical compositions |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4943587A (fr) |
| EP (1) | EP0342682A3 (fr) |
| JP (1) | JPH0236163A (fr) |
| KR (1) | KR890017233A (fr) |
| AU (1) | AU623900B2 (fr) |
| DK (1) | DK242389A (fr) |
| FI (1) | FI892322A7 (fr) |
| NO (1) | NO891951L (fr) |
| NZ (1) | NZ229174A (fr) |
| PT (1) | PT90602B (fr) |
| ZA (1) | ZA893578B (fr) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5068251A (en) * | 1988-12-16 | 1991-11-26 | Abbott Laboratories | Lipoxygenase inhibiting compounds |
| AU4717889A (en) * | 1988-12-29 | 1990-07-05 | Ciba-Geigy Ag | Amino-substituted hydroxamic acids |
| US4981865A (en) * | 1989-05-26 | 1991-01-01 | Warner-Lambert Co. | N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents |
| US5840749A (en) * | 1989-08-25 | 1998-11-24 | Hoechst Marion Roussel, Inc. | N-hydroxy-dibenz b,e!oxepinalkylamines, N-hydroxy-dibenz b,e!oxepinalkanoic acid amides and related heterocyclic analogues |
| US5229516A (en) * | 1989-10-27 | 1993-07-20 | American Home Products Corporation | Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase |
| US5015481A (en) * | 1990-05-03 | 1991-05-14 | G. D. Searle & Co. | Stabilized pharmaceutical admixture composition |
| US5097397A (en) * | 1990-10-04 | 1992-03-17 | Federal Signal Corporation | Non-linear signalling device for vehicles |
| US5189178A (en) * | 1990-11-21 | 1993-02-23 | Galardy Richard E | Matrix metalloprotease inhibitors |
| US5183900A (en) * | 1990-11-21 | 1993-02-02 | Galardy Richard E | Matrix metalloprotease inhibitors |
| US5268384A (en) * | 1990-11-21 | 1993-12-07 | Galardy Richard E | Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
| US5239078A (en) * | 1990-11-21 | 1993-08-24 | Glycomed Incorporated | Matrix metalloprotease inhibitors |
| IT1250691B (it) * | 1991-07-22 | 1995-04-21 | Giancarlo Santus | Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac. |
| US5594106A (en) * | 1993-08-23 | 1997-01-14 | Immunex Corporation | Inhibitors of TNF-α secretion |
| US6063818A (en) * | 1996-06-13 | 2000-05-16 | Cell Pathways Inc. | Substituted benzylidene indenyl formamides, acetamides and propionamides |
| US5965619A (en) * | 1996-06-13 | 1999-10-12 | Cell Pathways Inc. | Method for treating patients having precancerous lesions with substituted indene derivatives |
| US5998477A (en) * | 1996-06-13 | 1999-12-07 | Cell Pathways Inc. | Substituted methoxy benzylidene indenyl-acetic and propionic acids for treating patients with precancerous lesions |
| US6121321A (en) * | 1996-06-13 | 2000-09-19 | Cell Pathways, Inc. | Substituted methoxy benzylidene indenyl acetic and propionic acids for treating patients with precancerous lesions |
| US6071934A (en) * | 1997-03-25 | 2000-06-06 | Cell Pathways, Inc. | Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions |
| US5948779A (en) * | 1997-12-12 | 1999-09-07 | Cell Pathways, Inc. | Substituted condensation products of n-benzyl-3-indenyl acetamides with heterocyclic aldehydes |
| US6028116A (en) * | 1998-04-03 | 2000-02-22 | Cell Pathways, Inc. | Substituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasia |
| US6762182B1 (en) | 1999-01-07 | 2004-07-13 | Vanderbilt University | Converting cox inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors |
| US6207700B1 (en) | 1999-01-07 | 2001-03-27 | Vanderbilt University | Amide derivatives for antiangiogenic and/or antitumorigenic use |
| US6306890B1 (en) | 1999-08-30 | 2001-10-23 | Vanderbilt University | Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors |
| TWI335332B (en) * | 2001-10-12 | 2011-01-01 | Theravance Inc | Cross-linked vancomycin-cephalosporin antibiotics |
| EP1599449A2 (fr) | 2003-02-25 | 2005-11-30 | TopoTarget UK Limited | Composes d'acide carbamique comprenant un groupe heteroaryle bicyclique utilises en tant qu'inhibiteurs de hdac |
| WO2004087051A2 (fr) * | 2003-03-27 | 2004-10-14 | Merck & Co., Inc. | Compositions ophtalmiques pour traiter une hypertension oculaire |
| AU2005244770A1 (en) | 2004-04-26 | 2005-12-01 | Vanderbilt University | Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity |
| KR20070091682A (ko) * | 2004-12-23 | 2007-09-11 | 록스로 파마 인코퍼레이티드 | 케토롤락의 비내 투여용 치료 조성물 |
| CA2657691A1 (fr) | 2006-06-19 | 2007-12-27 | Vanderbilt University | Methodes et compositions de diagnostic et de ciblage therapeutique de cox-2 |
| CN102137656A (zh) * | 2008-06-13 | 2011-07-27 | 罗克斯罗制药公司 | 用于鼻内投予的酮咯酸医药调配物 |
| US8551454B2 (en) * | 2009-03-13 | 2013-10-08 | Luitpold Pharmaceuticals, Inc. | Device for intranasal administration |
| US8277781B2 (en) * | 2009-03-13 | 2012-10-02 | Luitpold Pharmaceuticals, Inc. | Device for intranasal administration |
| CN107233337A (zh) | 2009-04-29 | 2017-10-10 | 阿马里纳药物爱尔兰有限公司 | 含有epa和心血管剂的药物组合物以及使用其的方法 |
| CA2676946A1 (fr) | 2009-08-28 | 2011-02-28 | Lucie Peduto | Inhibiteurs de l'enzyme adam12 et leur utilisation contre la fibrose induite par l'inflammation |
| US9346803B2 (en) | 2011-10-17 | 2016-05-24 | Vanderbilt University | Indomethacin analogs for the treatment of castrate-resistant prostate cancer |
| US9058753B2 (en) | 2012-03-23 | 2015-06-16 | Documotion Research, Inc. | Paper, labels made therefrom and methods of making paper and labels |
| EP3410849B1 (fr) | 2016-02-05 | 2023-07-05 | Institut Pasteur | Utilisation d'inhibiteurs d'adam12 comme adjuvants dans les traitement antitumoraux |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1579495A (fr) * | 1968-01-22 | 1969-08-29 | ||
| IT1036004B (it) * | 1968-05-21 | 1979-10-30 | Abc Ist Biolog Chem Spa | Acidt 3 indolil adetoidrossamici |
| DE2008332C3 (de) * | 1970-02-23 | 1980-05-22 | Istituto Biologico Chemioterapico Abc S.P.A., Turin (Italien) | 2-Methyl-S-methoxy-3-indolylacetohydroxamsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US4173577A (en) * | 1970-09-09 | 1979-11-06 | Ciba-Geigy Corporation | Phenylacetohydroxamic acids |
| US4092430A (en) * | 1970-09-09 | 1978-05-30 | Ciba-Geigy Corporation | Antiphlogistic phenylacetohydroxamic acid compositions |
| US4029815A (en) * | 1975-04-30 | 1977-06-14 | Schering Corporation | Anti-diarrheal anthranilic acids |
| PT72878B (en) * | 1980-04-24 | 1983-03-29 | Merck & Co Inc | Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents |
| AU1933583A (en) * | 1982-09-22 | 1984-03-29 | Meiji Seika K.K. | Hydroxylamine derivatives |
| JP2559699B2 (ja) * | 1985-03-16 | 1996-12-04 | ザ ウエルカム フアウンデ−シヨン リミテツド | 新規なアリ−ル誘導体 |
| US4792560A (en) * | 1985-04-03 | 1988-12-20 | Rorer Pharmaceutical Corporation | Quinoline hydroxamates and their use as modulators of arachidonic acid metabolic pathways |
-
1988
- 1988-05-19 US US07/196,584 patent/US4943587A/en not_active Expired - Fee Related
-
1989
- 1989-04-27 AU AU33836/89A patent/AU623900B2/en not_active Ceased
- 1989-05-12 ZA ZA893578A patent/ZA893578B/xx unknown
- 1989-05-15 FI FI892322A patent/FI892322A7/fi not_active IP Right Cessation
- 1989-05-16 NO NO89891951A patent/NO891951L/no unknown
- 1989-05-17 NZ NZ229174A patent/NZ229174A/xx unknown
- 1989-05-18 PT PT90602A patent/PT90602B/pt not_active IP Right Cessation
- 1989-05-18 EP EP19890108976 patent/EP0342682A3/fr not_active Ceased
- 1989-05-18 JP JP1123016A patent/JPH0236163A/ja active Pending
- 1989-05-18 DK DK242389A patent/DK242389A/da unknown
- 1989-05-19 KR KR1019890006709A patent/KR890017233A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DK242389A (da) | 1989-11-20 |
| NO891951L (no) | 1989-11-20 |
| PT90602A (pt) | 1989-11-30 |
| KR890017233A (ko) | 1989-12-15 |
| AU623900B2 (en) | 1992-05-28 |
| US4943587A (en) | 1990-07-24 |
| NO891951D0 (no) | 1989-05-16 |
| PT90602B (pt) | 1994-09-30 |
| ZA893578B (en) | 1991-01-30 |
| FI892322A7 (fi) | 1989-11-20 |
| EP0342682A2 (fr) | 1989-11-23 |
| AU3383689A (en) | 1989-11-23 |
| JPH0236163A (ja) | 1990-02-06 |
| EP0342682A3 (fr) | 1991-12-11 |
| FI892322A0 (fi) | 1989-05-15 |
| DK242389D0 (da) | 1989-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU588365B2 (en) | Pharmaceutical compositions and medical uses of dioxopiperidine derivatives | |
| IL114536A (en) | Acyl derivatives of azolones their preparation and pharmaceutical compositions containing them | |
| PH25104A (en) | Acyl derivatives and pharmaceutical preparation thereof | |
| IL86502A0 (en) | Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives and pharmaceutical compositions containing them | |
| NZ228321A (en) | Benzopyran derivatives and pharmaceutical compositions | |
| IL88988A0 (en) | Didehydro-vitamin d3 derivatives and pharmaceutical compositions containing them | |
| DE69328492D1 (de) | Fettsäure-derivate und diese enthaltende pharmazeutische präparationen | |
| NZ216793A (en) | Phenethanolaminotetraline derivatives and pharmaceutical compositions | |
| NZ235109A (en) | Aminoacetamide derivatives and pharmaceutical compositions thereof | |
| IL87116A (en) | 9-halogen-(z)-prostaglandin derivatives and pharmaceutical compositions containing the same | |
| HU896612D0 (en) | Process for the preparation of 2-iminebenzothiazole derivatives and pharmaceutical compositions thereof | |
| HU896479D0 (en) | Process for the preparation of capsaycin derivatives and pharmaceutical compositions thereof | |
| HUP0001534A3 (en) | Phospholipid derivatives of phosphono-carboxylic acids and pharmaceutical compositions containing them | |
| NZ216649A (en) | Pharmaceutical and veterinary compositions containing synergistic mixtures of vitamin d 3 derivatives | |
| IL90613A0 (en) | Chroman derivatives and pharmaceutical compositions containing them | |
| NZ217078A (en) | N-piperidyl-benzamide derivatives and pharmaceutical compositions | |
| IL107627A0 (en) | Benzopyran derivatives their preparation and pharmaceutical compositions containing them | |
| NZ218237A (en) | Oxazolone derivatives and pharmaceutical compositions | |
| NZ218465A (en) | N-(pyrrol-1-yl)-pyridinamine derivatives and pharmaceutical compositions | |
| PH24960A (en) | Acyl derivatives and pharmaceutical preparation thereof | |
| NZ216720A (en) | Diazinylpiperidine derivatives and pharmaceutical compositions | |
| NZ225613A (en) | Benzazepin-2-one derivatives and pharmaceutical compositions | |
| HU895948D0 (en) | Process for the preparation of dipeptidecarbamide derivatives having inhibition of renine and pharmaceutical compositions thereof | |
| NZ220588A (en) | Diazole derivatives and pharmaceutical compositions | |
| NZ214815A (en) | 12-aminopyridazinopyrroloisoquinoline derivatives and pharmaceutical compositions |